Please Wait
Applying Filters...
USFDA APPLICATION NUMBER - 202806 / DOSAGE - CAPSULE;ORAL - EQ 50MG BASE
| Active Ingredient/Active Moiety | ||
| Ingredient Name | Basis of Strength | Strength |
|---|---|---|
| DABRAFENIB MESYLATE(UNII: B6DC89I63E) (DABRAFENIB - UNII:QGP4HA4G1B) | DABRAFENIB | 75mg | 50mg |
Inactive Ingredients
| Ingredient Name | GlaxoSmithKline Inc | GlaxoSmithKline LLC |
|---|---|---|
| FERRIC OXIDE RED(1K09F3G675) | ||
| HYPROMELLOSE, UNSPECIFIED(3NXW29V3WO) | ||
| MAGNESIUM STEARATE(70097M6I30) | ||
| MICROCRYSTALLINE CELLULOSE(OP1R32D61U) | ||
| SILICON DIOXIDE(ETJ7Z6XBU4) | ||
| TITANIUM DIOXIDE(15FIX9V2JP) |
LOOKING FOR A SUPPLIER?
